Regulations.gov document
Response Letter from FDA CDER to Hy-Gene Biomedical Corporation
Other · FDA-1975-N-0012 · posted Jan 17, 2023
Key facts
| Document ID | FDA-1975-N-0012-0842 |
|---|---|
| Title | Response Letter from FDA CDER to Hy-Gene Biomedical Corporation |
| Document type | Other |
| Subtype | Response(s) |
| Agency | FDA |
| Docket | FDA-1975-N-0012 |
| Posted | Jan 17, 2023 |
| Comment period opens | Jan 17, 2023 |
| Effective date | Jan 13, 2023 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: